Læknablaðið - 15.09.2009, Page 17

ÍH]stofal08
Áhrifaríkt
Einfalt
J

1 mg á dag
rasagílín
Einu sinni á dag
Heimildir Sérlyfjatexti á bls. 631
1. Parkinson Study Croup.A Controlled Trial of Rasagiline in Early Parkinson Disease.TheTEMPO Study. Arch Neurol 2002; 59:1937-43
2. Rascol et al, for the LARGO study group. Rasagiline as an adjunct to levodopa in patients with Parkinson’s disease and motor þuctuations (LARCO, Lasting effect in Adjunct therapy with
Rasagiline Civen Once daily, study): a randomised, double-blind, parallel-group trial. Lancet 2005; 365:947-54
3. Parkinson Study Croup.A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients With Parkinson Disease and Motor Fluctuations.The PRESTO Study.Arch Neurol
2005; 62: 241-248